Motus GI Holdings Looks For Strategic Alternatives
Motus GI Holdings Inc (NASDAQ:MOTS) has initiated a process to explore a range of strategic and financing alternatives. As part…
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
HC Wainwright & Co. Maintains Buy on Motus GI Hldgs, Lowers Price Target to $10
HC Wainwright & Co. analyst Yi Chen maintains Motus GI Hldgs (NASDAQ:MOTS) with a Buy and lowers the price target from $11 to $10.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Dow Rises 1.5%; Nasdaq Jumps Over 100 Points
U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 450 points on Monday.
Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge
U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday.
Motus GI Presents Clinical Data For Pure-Vu EVS In Three Poster Presentations At American College Of Gastroenterology (ACG) 2022 Annual Scientific Meeting Oct. 24 And 25
Positive clinical data from feasibility and efficacy study of the Pure-Vu EVS conducted by Minneapolis VA Health Care System
Overview of the results from an inpatient colonoscopy conducted at an ICU bedside when using
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers
Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.